Skip to main content

Table 10 Diagnostic performance of baseline AFP and amphiregulin in predicting tumor recurrence

From: Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment

Marker

AUC

Sensitivity (%)

Specificity (%)

SE

P

95% CI

Cutoff

Baseline AFP

0.632

80

56

0.095

0.359

0.445–0.819

≥ 439.0

Baseline amphiregulin

0.552

80

40

0.137

0.718

0.284–0.820

≥ 17.0